Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus
- PMID: 65445
- DOI: 10.1099/0022-1317-34-2-397
Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus
Abstract
The specificity of guinea pig antisera against large cyanogen bromide-cleaved peptides of the virus capsid protein VP3 of foot-and-mouth disease virus type O1, strain Kaufbeuren has been characterized by double immunodiffusion, virus neutralization and protection tests. Antibodies to purified 146S particles and the cleavage peptides of VP3 showed an incomplete cross-section against VP3 peptide antigen when reacted in immunodiffusion tests, indicating that new antigenic determinants are exhibited by the peptides which are not recognized by the antiserum against the native virus proteins. The immune response against the reduced, unfolded chain constituents of VP3 was lower in comparison to that of native virus particles but still some immunological determinants remained actively capable of inducing virus-neutralizing antibodies in immunized guinea pigs.
Similar articles
-
Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.J Immunol. 1975 Dec;115(6):1636-41. J Immunol. 1975. PMID: 171309
-
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.J Gen Virol. 1979 Dec;45(3):761-3. doi: 10.1099/0022-1317-45-3-761. J Gen Virol. 1979. PMID: 94352
-
The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.Virology. 1998 Jul 20;247(1):51-61. doi: 10.1006/viro.1998.9175. Virology. 1998. PMID: 9683571
-
New approaches to vaccination against foot-and-mouth disease.Vaccine. 1992;10(14):1022-6. doi: 10.1016/0264-410x(92)90111-v. Vaccine. 1992. PMID: 1335197 Review.
-
Influence of local structure on the location of antigenic determinants in tobacco mosaic virus protein.Ciba Found Symp. 1986;119:76-92. doi: 10.1002/9780470513286.ch5. Ciba Found Symp. 1986. PMID: 2426056 Review.
Cited by
-
Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.J Virol. 1984 Nov;52(2):465-73. doi: 10.1128/JVI.52.2.465-473.1984. J Virol. 1984. PMID: 6208377 Free PMC article.
-
Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles.Arch Virol. 1982;74(1):1-9. doi: 10.1007/BF01320777. Arch Virol. 1982. PMID: 6186225
-
Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.Virus Genes. 1997;14(3):255-9. doi: 10.1023/a:1007996213037. Virus Genes. 1997. PMID: 9311571
-
Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.Virus Genes. 1994 Jul;8(3):199-214. doi: 10.1007/BF01703078. Virus Genes. 1994. PMID: 7975267 Review.
-
Computer simulations to identify in polyproteins of FMDV OK1 and A12 strains putative nonapeptides with amino acid motifs for binding to BoLA class I A11 and A20 haplotype molecules.Virus Genes. 1997;14(2):123-9. doi: 10.1023/a:1007965200932. Virus Genes. 1997. PMID: 9237351
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources